- 26 Aug 2021 Form 3 Insider Report for Humacyte, Inc. (HUMA)

Role: 10%+ Owner
Signature: FRESENIUS MEDICAL CARE HOLDINGS, INC. /s/ Mark Fawcett By: Mark Fawcett Senior Vice President and Treasurer
Issuer symbol: HUMA
Transactions as of: 26 Aug 2021
Net transactions value: $0
Form type: 3
Filing time: 02 Sep 2021, 06:05:28 UTC
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	HUMA	Common Stock, par value $0.0001 per share						18,312,735	26 Aug 2021	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Excludes the Reporting Person's pro rata share of up to 15,000,000 additional shares of the Issuer's Common Stock which may become issuable to the former shareholders of Humacyte, Inc. pursuant to the terms of the Business Combination Agreement dated as of February 17, 2021 by and among the Issuer, Hunter Merger Sub, Inc. and Humacyte, Inc., as to which the Reporting Person disclaims any present beneficial ownership interest.
F2	Fresenius Medical Care Holdings, Inc. is an indirect, wholly-owned subsidiary of Fresenius Medical Care AG & Co. KGaA ("FMC AG & Co. KGaA"). FMC AG & Co. KGaA's address is Else-Kroner Strasse 1, 61352 Bad Homburg, Germany.

Content

Excludes the Reporting Person's pro rata share of up to 15,000,000 additional shares of the Issuer's Common Stock which may become issuable to the former shareholders of Humacyte, Inc. pursuant to the terms of the Business Combination Agreement dated as of February 17, 2021 by and among the Issuer, Hunter Merger Sub, Inc. and Humacyte, Inc., as to which the Reporting Person disclaims any present beneficial ownership interest.

Fresenius Medical Care Holdings, Inc. is an indirect, wholly-owned subsidiary of Fresenius Medical Care AG & Co. KGaA ("FMC AG & Co. KGaA"). FMC AG & Co. KGaA's address is Else-Kroner Strasse 1, 61352 Bad Homburg, Germany.